New Edition,classified

Antimicrobial peptides (AMPs), also known as host defense peptides (HDPs), represent a vital component of the innate immune response across all classes of life. These small peptides are natural compounds that exhibit antimicrobial properties, acting as a first line of defense against invading pathogens. Understanding the classification of AMPs is crucial for unraveling their diverse mechanisms of action and harnessing their potential for therapeutic and industrial applications.

The study of antimicrobial peptides classification has evolved significantly, with various systems emerging based on different criteria. These peptides are classified broadly, reflecting their widespread presence and varied origins. Indeed, AMPs are a class of small peptides that widely exist in nature and are found in organisms spanning six life kingdoms: bacteria, archaea (prokaryotes), protists, fungi, plants, and animals (eukaryotes). This broad distribution underscores their fundamental role in biological systems.

One of the most common approaches to antimicrobial peptides classification is based on their secondary structure. According to this method, AMPs can be divided into four major categories: α-helical peptides, β-sheet peptides, αβ-peptides (possessing both helical and sheet structures), and peptides lacking significant secondary structure. These structures are critical for their interaction with microbial membranes. Furthermore, folded AMPs can be classified into groups based on their secondary structure, including α-helical, β-sheet, and extended structures.

Another significant classification system categorizes AMPs based on their charge. Many AMPs are cationic and amphipathic, meaning they possess both positive charges and distinct hydrophilic and hydrophobic regions. This characteristic is vital for their ability to disrupt microbial cell membranes. Within this structural framework, AMPs can be further delineated into anionic peptide and cationic peptide groups, with some exhibiting mixed properties. The ionic and amphipathic nature is a recurring theme in their function.

The origin and synthesis of AMPs also provide a basis for their classification. Bacteriocins are antimicrobial peptides produced by bacteria, often through ribosomal synthesis, as a means to eliminate competing organisms. AMPs can be broadly distinguished as either ribosomally synthesized or non-ribosomally synthesized peptides. Databases like DBAASP catalog ribosomal, non-ribosomal, and synthetic peptides that demonstrate antimicrobial activity.

Beyond structural and origin-based classifications, AMPs can also be categorized by their targeted pathogens. This functional classification includes antibacterial, antifungal, antiparasitic, and antiviral peptides. This highlights the broad spectrum of activity that these versatile molecules can possess. For instance, specific AMPs are known to target bacterial membranes, leading to cell lysis. These are often referred to as membrane peptides.

The nomenclature of AMPs also plays a role in their identification and understanding. Some systems utilize peptide property-based naming conventions, such as LL-37, which refers to a 37-residue human innate immune peptide. Ultimately, AMPs are short protein fragments, typically made up of around 12 to 50 amino acids, and their diverse structures and properties contribute to their significant role in host defense and their vast potential in various applications, from therapeutics to food preservation. Their status as part of the innate immune response found among all classes of life solidifies their importance in biological systems. They are also described as a class of alkaline, small molecules found widely in nature. The ongoing research into antimicrobial peptides continues to refine our understanding of their complex classification and expand their therapeutic horizons.